Skip to content

Tom Howell Jr.

Tom Howell Jr.

Tom Howell Jr. covers politics and the White House for The Washington Times. He can be reached at thowell@washingtontimes.com.

Articles by Tom Howell Jr.

Vice President Kamala Harris listens as President Joe Biden speaks about the economy, in the East Room of the White House, Monday, May 10, 2021, in Washington. (AP Photo/Evan Vucci) **FILE**

Biden, governors brainstorm vaccine incentives, mobile efforts

Governors on Tuesday told President Biden they are doing what they can to root out Americans who remain unvaccinated for COVID-19, offering shots to baseball fans and throwing L.L. Bean gift cards and free fishing licenses at outdoorsmen in Maine. Published May 11, 2021

Caitlyn Jenner speaks at the fourth Women's March in Los Angeles. (AP Photo/Damian Dovarganes, File)

Caitlyn Jenner: I played golf instead of voting in 2020

Caitlyn Jenner, running to unseat California Gov. Gavin Newsom in a recall election, said she didn't bother to vote for then-President Donald Trump in November 2020 or show up at the polls at all. Published May 11, 2021

A sign looking to hire employees is displayed at the entrance to a Bed, Bath and Beyond store, Tuesday, May 4, 2021, in Miami. (AP Photo/Marta Lavandier) ** FILE **

WH: Unemployment benefits not 'major driver' of poor jobs report

The White House said Monday it does not believe generous unemployment insurance is keeping people out of the workforce and that factors such as a lack of child care, a desire for better wages and lingering fears of the virus are bigger factors. Published May 10, 2021

Eunsun Kim, originally from Korea, is vaccinated with the Pfizer-BioNTech vaccine at the Mexican Consulate as a Mariachi Serenade band performs in Los Angeles Saturday, May 8, 2021. CHIRLA, the Coalition for Humane Immigrant Rights, and the Mexican Consulate in Los Angeles are holding two days of COVID-19 vaccination clinic this week, where members of the immigrant community can get their vaccine without an appointment. (AP Photo/Damian Dovarganes)

Pfizer partner BioNTech is exploring a variant-specific vaccine strategy

German company BioNTech told investors Monday there is "no evidence" it must change the vaccine it developed with Pfizer to cope with coronavirus variants that are pinging around the globe, but it is exploring contingency plans with U.S. regulators anyway. Published May 10, 2021